U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06842264) titled 'The Development and Validation of MRI-AI-based Predictive Models for CsPCa' on Feb. 11.
Brief Summary: This study retrospectively included patients who underwent prostate magnetic resonance imaging (MRI) and subsequent ultrasound-guided prostate biopsy at Peking University First Hospital from January 2019 to December 2023, and prospectively enrolls patients from January 2024 to December 2029. Clinical information such as age, PSA levels, PI-RADS scores, and digital rectal examination findings are collected. A well-performing artificial intelligence model is employed to measure prostate volume, transitional zone volume, and lesion vo...